Results 291 to 300 of about 2,308,170 (352)

Global 'side effects' of the EU's pharmaceutical reforms and their impact on access to medicines in LMICs. [PDF]

BMJ Glob Health
Perehudoff K.
europepmc   +1 more source

Dataset-Learning Duality and Emergent Criticality. [PDF]

Entropy (Basel)
Kukleva E, Vanchurin V.
europepmc   +1 more source

Is the current regulatory framework for direct-to-consumer microbiome-based tests sufficient to protect consumers from medical, economic, and dignitary harms? [PDF]

J Law Biosci
Hoffmann DE, Langel FD, von Rosenvinge EC, Palumbo FB, Roghmann MC, Ravel J.   +5 more
europepmc   +1 more source

Drug advertisements in daily newspapers: a case study with the Hannoversche Allgemeine Zeitung (Hannover General Newspaper). [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Wafai G, Seifert R.
europepmc   +1 more source

Companies Formation, Management, and Winding-Up Procedure & Accounts with the Law Relating Thereto.

, 2013
Robert Longfield Sidey
openalex   +1 more source

CBPR is indeed political. [PDF]

Lancet Reg Health Am
Cross RI, Huynh J, Rogers TB, Bradford NJ, Sharif MZ.   +4 more
europepmc   +1 more source

Revitalising Gower's Legacy: Reforming Company Law in Ghana

, 2011
Kofi Date-Bah
openalex   +1 more source

Emerging toxicological awareness of per- and polyfluoroalkyl substances: the rising concern over 'forever chemicals'.

Dis Model Mech
DeWitt JC, Goldenman G, Lohmann R, Ng CA, Wang Z.   +4 more
europepmc   +1 more source

Annual Reports to the ESA Council ESA 110th Annual Meeting July, 2025

The Bulletin of the Ecological Society of America, EarlyView.
wiley   +1 more source